X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (59523) 59523
Newsletter (26320) 26320
Publication (4181) 4181
Newspaper Article (2262) 2262
Book Review (246) 246
Book Chapter (105) 105
Dissertation (97) 97
Conference Proceeding (61) 61
Magazine Article (58) 58
Trade Publication Article (50) 50
Transcript (11) 11
Book / eBook (10) 10
Web Resource (6) 6
Data Set (5) 5
Reference (3) 3
Government Document (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lung cancer, non-small cell (55321) 55321
humans (35211) 35211
cancer (34558) 34558
research (29895) 29895
oncology (25018) 25018
index medicus (23996) 23996
care and treatment (20966) 20966
female (20638) 20638
male (20333) 20333
oncology, experimental (18161) 18161
lung cancer (17783) 17783
middle aged (17743) 17743
lung neoplasms - pathology (17684) 17684
aged (17275) 17275
carcinoma, non-small-cell lung - pathology (16371) 16371
chemotherapy (15666) 15666
lung cancer, small cell (14376) 14376
carcinoma, non-small-cell lung - drug therapy (13488) 13488
non-small cell lung cancer (13219) 13219
lung neoplasms - drug therapy (13187) 13187
prognosis (12340) 12340
adult (11069) 11069
reports (9947) 9947
carcinoma, non-small-cell lung - genetics (9219) 9219
metastasis (9156) 9156
analysis (9096) 9096
lung neoplasms - genetics (9085) 9085
genetic aspects (9016) 9016
neoplasm staging (8495) 8495
respiratory system (8100) 8100
tumors (7765) 7765
aged, 80 and over (7524) 7524
lung neoplasms - mortality (7224) 7224
carcinoma, non-small-cell lung - mortality (7139) 7139
survival (7033) 7033
radiotherapy (6270) 6270
treatment outcome (6248) 6248
lung neoplasms - metabolism (6116) 6116
carcinoma, non-small-cell lung - metabolism (5997) 5997
health aspects (5861) 5861
non-small cell lung carcinoma (5693) 5693
mutation (5619) 5619
apoptosis (5577) 5577
carcinoma (5520) 5520
surgery (5481) 5481
physical fitness (5370) 5370
expression (5169) 5169
antineoplastic combined chemotherapy protocols - therapeutic use (5001) 5001
cell line, tumor (4967) 4967
development and progression (4922) 4922
nsclc (4785) 4785
epidermal growth factor (4728) 4728
hematology, oncology and palliative medicine (4714) 4714
retrospective studies (4705) 4705
drug therapy (4689) 4689
medical research (4668) 4668
lung neoplasms - surgery (4586) 4586
carcinoma, non-small-cell lung - surgery (4573) 4573
gefitinib (4556) 4556
clinical trials (4506) 4506
universities and colleges (4464) 4464
antineoplastic agents (4365) 4365
adenocarcinoma (4272) 4272
survival rate (4246) 4246
antimitotic agents (4244) 4244
cancer therapies (4170) 4170
antineoplastic agents - therapeutic use (3963) 3963
survival analysis (3940) 3940
non-small-cell lung cancer (3897) 3897
patients (3840) 3840
medicine, experimental (3768) 3768
animals (3761) 3761
patient outcomes (3668) 3668
biochemistry (3662) 3662
cisplatin (3626) 3626
respiratory tract diseases (3539) 3539
gene expression (3512) 3512
diagnosis (3442) 3442
immunohistochemistry (3385) 3385
carcinoma, non-small-cell lung - radiotherapy (3315) 3315
therapy (3302) 3302
pharmaceutical industry (3238) 3238
lung neoplasms - radiotherapy (3234) 3234
immunotherapy (3216) 3216
erlotinib (3205) 3205
lung neoplasms - therapy (3203) 3203
carcinoma, non-small-cell lung - therapy (3177) 3177
proteins (3049) 3049
disease-free survival (2981) 2981
cell lung-cancer (2926) 2926
medical prognosis (2840) 2840
lung neoplasms - diagnosis (2755) 2755
medicine & public health (2752) 2752
risk factors (2691) 2691
carcinoma, non-small-cell lung - diagnosis (2689) 2689
receptor, epidermal growth factor - genetics (2638) 2638
follow-up studies (2613) 2613
kinases (2606) 2606
mice (2585) 2585
radiation (2512) 2512
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (85777) 85777
Chinese (1183) 1183
French (438) 438
Japanese (273) 273
German (240) 240
Korean (135) 135
Polish (89) 89
Spanish (61) 61
Russian (45) 45
Italian (35) 35
Portuguese (30) 30
Turkish (27) 27
Czech (19) 19
Hungarian (15) 15
Icelandic (6) 6
Serbian (6) 6
Dutch (5) 5
Croatian (2) 2
Hebrew (2) 2
Romanian (2) 2
Slovak (2) 2
Belarusian (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Danish (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Persian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Disease, ISSN 2072-1439, 2013, Volume 5, Issue 4, pp. S389 - S396
Radical surgery is the standard of care for fit stage I non-small cell lung cancer (NSCLC) patients. Adjuvant treatment should be offered only as part of an... 
Targeted treatment | Treatment | Lung cancer | Non-small cell lung cancer (NSCLC) | ADJUVANT CHEMOTHERAPY | treatment | THYMIDYLATE SYNTHASE | RANDOMIZED-TRIAL | targeted treatment | lung cancer | PHASE-III TRIAL | SUPPORTIVE CARE | RESPIRATORY SYSTEM | QUALITY-OF-LIFE | PACLITAXEL PLUS CARBOPLATIN | COMPARING CISPLATIN | UNTREATED PATIENTS | COOPERATIVE-ONCOLOGY-GROUP | Review
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2016, Volume 22, Issue 18, pp. 4585 - 4593
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2011, Volume 129, Issue 11, pp. 2621 - 2631
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2013, Volume 108, Issue 10, pp. 2021 - 2032
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2015, Volume 26, Issue 5, pp. 894 - 901
Background: KRAS mutations are detected in 25% of non-small-cell lung cancer (NSCLC) and no targeted therapies are approved for this subset population.... 
KRAS | MEK inhibitor | NSCLC | Progression-free survival | Trametinib | Docetaxel | SURVIVAL | CRITERIA | EFFICACY | progression-free survival | BEHAVIOR | ADENOCARCINOMAS | trametinib | TYROSINE KINASE INHIBITORS | GROWTH-FACTOR RECEPTOR | ONCOGENE | MEK INHIBITION | ONCOLOGY | docetaxel | MUTATIONS | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Taxoids - therapeutic use | Time Factors | Adult | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | MAP Kinase Kinase 1 - antagonists & inhibitors | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Kaplan-Meier Estimate | MAP Kinase Kinase 1 - metabolism | Treatment Outcome | MAP Kinase Kinase 2 - metabolism | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Disease-Free Survival | Signal Transduction - drug effects | MAP Kinase Kinase 2 - antagonists & inhibitors | Protein Kinase Inhibitors - therapeutic use | Aged | Biomarkers, Tumor - genetics | Pyridones - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Pyridones - adverse effects | Original
Journal Article